Goldman Sachs Group Inc Utah Medical Products Inc Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Utah Medical Products Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 5,133 shares of UTMD stock, worth $288,474. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,133

Previous 4,891 4.95%

Holding current value

$288,474

Previous $278,000 16.19%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$54.95 - $63.44 $13,297 - $15,352	242 Added 4.95%	5,133 $323,000
Q2 2025 Aug 14, 2025	SELL	$51.75 - $57.36 $486,191 - $538,897	-9,395 Reduced 65.76%	4,891 $278,000
Q1 2025 May 09, 2025	SELL	$56.04 - $64.17 $27,739 - $31,764	-495 Reduced 3.35%	14,286 $800,000
Q4 2024 Feb 11, 2025	BUY	$60.9 - $68.52 $473,680 - $532,948	7,778 Added 111.07%	14,781 $908,000
Q3 2024 Nov 14, 2024	BUY	$65.79 - $75.08 $256,449 - $292,661	3,898 Added 125.54%	7,003 $468,000

Q2 2024 Aug 13, 2024	SELL	$65.92 - $70.99 $302,902 - $326,199	-4,595 Reduced 59.68%	3,105 $207,000
Q1 2024 May 15, 2024	SELL	$68.14 - $84.23 $1.83 Million - $2.26 Million	-26,812 Reduced 77.69%	7,700 $547,000
Q4 2023 Feb 13, 2024	SELL	$77.07 - $87.05 $496,639 - $560,950	-6,444 Reduced 15.73%	34,512 $2.91 Million
Q3 2023 May 14, 2024	BUY	$83.86 - $99.16 $540,393 - $638,987	6,444 Added 18.67%	40,956 $3.52 Million
Q3 2023 Nov 14, 2023	BUY	$83.86 - $99.16 $8,386 - $9,916	100 Added 0.24%	40,956 $3.52 Million
Q2 2023 May 14, 2024	SELL	$87.76 - $99.95 $228,527 - $260,269	-2,604 Reduced 5.99%	40,856 $3.81 Million
Q2 2023 Aug 14, 2023	SELL	$87.76 - $99.95 $228,527 - $260,269	-2,604 Reduced 5.99%	40,856 $3.81 Million
Q1 2023 May 14, 2024	BUY	$87.14 - $100.3 $214,800 - $247,239	2,465 Added 6.01%	43,460 $4.12 Million
Q1 2023 May 11, 2023	BUY	$87.14 - $100.3 $214,800 - $247,239	2,465 Added 6.01%	43,460 $4.12 Million
Q4 2022 May 14, 2024	BUY	$82.45 - $101.88 $412 - $509	5 Added 0.01%	40,995 $4.12 Million
Q4 2022 Feb 13, 2023	BUY	$82.45 - $101.88 $412 - $509	5 Added 0.01%	40,995 $4.12 Million
Q3 2022 May 14, 2024	BUY	$80.73 - $95.26 $826,029 - $974,700	10,232 Added 33.27%	40,990 $3.5 Million
Q3 2022 Nov 10, 2022	BUY	$80.73 - $95.26 $826,029 - $974,700	10,232 Added 33.27%	40,990 $0
Q2 2022 May 14, 2024	SELL	$81.49 - $90.28 $305,913 - $338,911	-3,754 Reduced 10.88%	30,758 $2.64 Million
Q2 2022 Aug 15, 2022	BUY	$81.49 - $90.28 $118,730 - $131,537	1,457 Added 4.97%	30,758 $2.64 Million
Q1 2022 May 16, 2022	SELL	$86.04 - $99.89 $345,794 - $401,457	-4,019 Reduced 12.06%	29,301 $2.63 Million
Q4 2021 Feb 14, 2022	SELL	$88.84 - $124.71 $92,660 - $130,072	-1,043 Reduced 3.04%	33,320 $3.33 Million
Q3 2021 Nov 10, 2021	BUY	$84.89 - $97.16 $2.92 Million - $3.34 Million	34,363 New	34,363 $3.19 Million

Others Institutions Holding UTMD

# of Institutions

116

Shares Held

2.14M

Call Options Held

Put Options Held

View Full List

About UTAH MEDICAL PRODUCTS INC

Ticker UTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 3,625,200
Market Cap $204M
Description
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...

More about UTMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Utah Medical Products Inc Transaction History